Inventor · disambiguated record
William W. Bachovchin
Also filed as: BACHOVCHIN WILLIAM · BACHOVCHIN WILLIAM W
62 granted patents·39 pending applications·1,204 citations·filing 1987–2025
99Inventor score
Files withTUFTS COLLEGE63BACHOVCHIN WILLIAM W21BACH BIOSCIENCES LLC9AVACTA LIFE SCIENCES LTD2NEW ENGLAND MEDICAL CENTER INC2
Top patents by PatentIndex Score
101 records- 0198US6890898B2Method of regulating glucose metabolism, and reagents related theretoNEW ENGLAND MEDICAL CENTER INC·Filed 2002·Granted May 10, 2005·131 cites·88 claims
- 0297US10517955B2FAP-activated proteasome inhibitors for treating solid tumorsTUFTS COLLEGE·Filed 2018·Granted Dec 31, 2019·9 cites·18 claims
- 0397US9956297B2FAP-activated proteasome inhibitors for treating solid tumorsTUFTS COLLEGE·Filed 2016·Granted May 1, 2018·10 cites·18 claims
- 0497US5965532AMultivalent compounds for crosslinking receptors and uses thereofTUFTS COLLEGE·Filed 1997·Granted Oct 12, 1999·120 cites·11 claims
- 0597US4935493AProtease inhibitorsDU PONT·Filed 1987·Granted Jun 19, 1990·240 cites·12 claims
- 0696US11266669B2FAP-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2020·Granted Mar 8, 2022·4 cites·39 claims
- 0796US9597410B2FAP-activated proteasome inhibitors for treating solid tumorsBACHOVCHIN WILLIAM W·Filed 2012·Granted Mar 21, 2017·16 cites·27 claims
- 0896US7829530B2Method of regulating glucose metabolism, and reagents related theretoTUFTS COLLEGE·Filed 2008·Granted Nov 9, 2010·28 cites·6 claims
- 0996US5462928AInhibitors of dipeptidyl-aminopeptidase type IVNEW ENGLAND MEDICAL CENTER INC·Filed 1993·Granted Oct 31, 1995·193 cites·13 claims
- 1095US11957657B2Combination therapies using immuno-dash inhibitors and PGE2 antagonistsTUFTS COLLEGE·Filed 2021·Granted Apr 16, 2024·2 cites·17 claims
- 1195US11096924B2Combination therapies using immuno-dash inhibitors and PGE2 antagonistsTUFTS COLLEGE·Filed 2017·Granted Aug 24, 2021·6 cites·29 claims
- 1295US9737556B2FAP-activated therapeutic agents, and uses related theretoTUFTS COLLEGE·Filed 2015·Granted Aug 22, 2017·8 cites·8 claims
- 1394US10117887B2FAP-activated therapeutic agents, and uses related theretoTUFTS COLLEGE·Filed 2017·Granted Nov 6, 2018·6 cites·39 claims
- 1494US9839646B2Small molecule enhancer for dendritic cell cancer vaccinesTUFTS COLLEGE·Filed 2015·Granted Dec 12, 2017·6 cites·16 claims
- 1594US7078381B2Method of regulating glucose metabolism, and reagents related theretoTUFTS COLLEGE·Filed 2004·Granted Jul 18, 2006·32 cites·81 claims
- 1693US10709722B2FAP-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2018·Granted Jul 14, 2020·5 cites·33 claims
- 1793US7459428B2Method of regulating glucose metabolism, and reagents related theretoTUFTS COLLEGE·Filed 2006·Granted Dec 2, 2008·12 cites·24 claims
- 1892US7994121B2Stable analogs of peptide and polypeptide therapeuticsTUFTS COLLEGE·Filed 2007·Granted Aug 9, 2011·16 cites·17 claims
- 1991US11583516B2Dash inhibitors, and uses related theretoTUFTS COLLEGE·Filed 2017·Granted Feb 21, 2023·3 cites·18 claims
- 2091US6825169B1Inhibitors of dipeptidyl-aminopeptidase type IVTUFTS COLLEGE·Filed 1997·Granted Nov 30, 2004·65 cites·8 claims
- 2190US9284337B2Small molecule enhancer for dendritic cell cancer vaccinesTUFTS COLLEGE·Filed 2012·Granted Mar 15, 2016·4 cites·13 claims
- 2290US5580979APhosphotyrosine peptidomimetics for inhibiting SH2 domain interactionsTRUSTEES OF TUFTS UNIVERSITY·Filed 1994·Granted Dec 3, 1996·105 cites·8 claims
- 2389US12478609B2Combination therapies using immuno-DASH inhibitors and PGE2 antagonistsTUFTS COLLEGE·Filed 2024·Granted Nov 25, 2025·0 cites·18 claims
- 2489US8268880B2Soft protease inhibitors and pro-soft forms thereofBACHOVCHIN WILLIAM W·Filed 2006·Granted Sep 18, 2012·9 cites·16 claims
- 2589US7259234B2Stable analogs of peptide and polypeptide therapeuticsTUFTS COLLEGE·Filed 2004·Granted Aug 21, 2007·25 cites·6 claims
- 2688US10245248B2FAP-activated therapeutic agents, and uses related theretoTUFTS COLLEGE·Filed 2015·Granted Apr 2, 2019·5 cites·11 claims
- 2788US2025108031A1Fap-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 2887US11065339B2FAP-activated proteasome inhibitors for treating solid tumorsTUFTS COLLEGE·Filed 2019·Granted Jul 20, 2021·1 cites·10 claims
- 2987US2024398842A1Fap-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 3086US11559537B2Combination therapies using caspase-1 dependent anticancer agents and PGE2 antagonistsTUFTS COLLEGE·Filed 2018·Granted Jan 24, 2023·2 cites·24 claims
- 3186US8933056B2Soft protease inhibitors and pro-soft forms thereofTUFTS COLLEGE·Filed 2013·Granted Jan 13, 2015·5 cites·3 claims
- 3286US7998997B2Inhibitors of fibroblast activation protein alphaTUFTS COLLEGE·Filed 2006·Granted Aug 16, 2011·7 cites·7 claims
- 3385US11033525B2Fap-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2019·Granted Jun 15, 2021·1 cites·12 claims
- 3485US8318669B2Method of regulating glucose metabolism, and reagents related theretoBACHOVCHIN WILLIAM W·Filed 2010·Granted Nov 27, 2012·4 cites·27 claims
- 3585US7569546B2Apolipoprotein A1 mimetics and uses thereofTUFTS COLLEGE·Filed 2005·Granted Aug 4, 2009·5 cites·5 claims
- 3685US5776902ABoronophenyl analogs of phospholyrosinesTRUSTEES OF TUFTS UNIVERSITY·Filed 1995·Granted Jul 7, 1998·46 cites·15 claims
- 3783US8889720B2Non-flushing niacin analogues, and methods of use thereofTUFTS COLLEGE·Filed 2012·Granted Nov 18, 2014·4 cites·34 claims
- 3883US2023390241A1Dash inhibitors, and uses related theretoTUFTS COLLEGE·Filed 2023·Application pending·0 cites
- 3981US9044424B2Methods of regulating glucose metabolism, and reagents related theretoTUFTS COLLEGE·Filed 2013·Granted Jun 2, 2015·2 cites·30 claims
- 4080US11925655B2FAP-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2022·Granted Mar 12, 2024·0 cites·20 claims
- 4180US8513190B2Method of regulating glucose metabolism, and reagents related theretoBACHOVCHIN WILLIAM W·Filed 2011·Granted Aug 20, 2013·2 cites·30 claims
- 4280US6875737B1Multivalent compounds for crosslinking receptors and uses thereofTUFTS COLLEGE·Filed 1999·Granted Apr 5, 2005·28 cites·21 claims
- 4379US12214047B2FAP-activated proteasome inhibitors for treating solid tumorsTUFTS COLLEGE·Filed 2021·Granted Feb 4, 2025·0 cites·21 claims
- 4479US9193708B2Non-flushing niacin analogues, and methods of use thereofTUFTS COLLEGE·Filed 2014·Granted Nov 24, 2015·2 cites·10 claims
- 4579US8377971B2Non-flushing niacin analogues, and methods of use thereofTUFTS COLLEGE·Filed 2007·Granted Feb 19, 2013·2 cites·8 claims
- 4679US8124580B2Apolipoprotein A1 mimetics and uses thereofBACHOVCHIN WILLIAM W·Filed 2009·Granted Feb 28, 2012·2 cites·15 claims
- 4779US2025367304A1Fap-activated proteasome inhibitors for treating solid tumorsTUFTS COLLEGE·Filed 2025·Application pending·0 cites
- 4878US7691967B2Smart pro-drugs of serine protease inhibitorsTUFTS COLLEGE·Filed 2003·Granted Apr 6, 2010·7 cites·15 claims
- 4978US7230074B2Inhibitors of dipeptidyl-aminopeptidase type IVTUFTS COLLEGE·Filed 2004·Granted Jun 12, 2007·9 cites·23 claims
- 5077US12053450B2FAP-activated therapeutic agents, and uses related theretoBACH BIOSCIENCES LLC·Filed 2021·Granted Aug 6, 2024·0 cites·17 claims
Showing the top 50 of 101 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when William W. Bachovchin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →